Presenters
Find A Presenter:
Michael Bennett
Michael F. Bennet was elected United States Senator for Colorado in November 2010. A newcomer to politics with experience in business and public service, he is widely-recognized as a pragmatic, innovative and independent thinker driven […]
Molly Burhans
Molly Burhans combines her passion for people and the planet with her experience in design thinking, business development, and scientific research to understand and transform complex systems and make land work for good. As the Founder and Executive Director of GoodLands, Burhans brings her unique combination of skills and networks together to help communities manage their property for environmental, social, and financial impact.
It’s the End of the World as We Know It (and I feel fine)
Aaron Clauset
Aaron Clauset is an Associate Professor in the Department of Computer Science and the BioFrontiers Institute at the University of Colorado Boulder and is External Faculty at the Santa Fe Institute. He received a Ph.D. in Computer Science, with distinction, from the University of New Mexico, a BS in Physics, with honors, from Haverford College, and was an Omidyar Fellow at the prestigious Santa Fe Institute.
Prediction and Its Limits in Scientific Discovery
Ruth Crowe
Ruth Crowe was trained as a physician-scientist at NYU School of Medicine and received residency and Hematology-Oncology fellowship training at Cornell University Medical College.
Healthcare on the Ground: New Challenges for Physicians
Robin Dowell
Robin Dowell is an Associate Professor in Molecular, Cellular, and Developmental Biology and Computer Science at University of Colorado Boulder. Dr. Dowell earned two bachelor’s degrees (Computer Engineering and Genetics) from Texas A&M University, a D.Sc. in Biomedical Engineering from Washington University in St Louis, and did postdoctoral research at MIT.
Cracking the Regulation Code
Jesse Gillis
Dr. Gillis obtained his Ph.D. in Computational Neuroscience from the University of Toronto where he also focused on large-scale integration of expression data to improve understanding of gene function for his post-doc studies. His research aims to help understand the flow of information from the genome to whole-organism biology through modeling and analysis of functional genomics data.
The Transcriptional Legacy of Developmental Stochasticity
Larry Gold
One to Five, Six to Ten Opening Remarks 2014 Closing Remarks 2014 Opening Remarks 2013 Opening Remarks 2012 Opening Remarks 2011 Closing Remarks 2010 Opening Remarks 2010 2019 GoldLab Symposium Closing Remarks 2021 GoldLab Symposium Closing Remarks Day 1 2021 GoldLab Symposium Closing Remarks Day 2
Nebojsa Janjic
Nebojsa Janjic is the Chief Science Officer at SomaLogic. He received his bachelor’s degree in molecular biology and doctorate in physical organic chemistry from the University of Washington in Seattle. He then went on to complete his postdoctoral training at the Scripps Research Institute in La Jolla as a Cancer Research Institute Fellow.
Measuring Proteins with DNA. Twisting the Central Dogma for Better Understanding of Biology.
Jo Marchant
Jo Marchant is an award-winning science journalist and author of several books including the New York Times bestseller Cure: A journey into the science of mind over body (2016).
A Journey into the Science of Mind Over Body
Emmanuel Mignot
Emmanuel Mignot, MD, is a Professor of Psychiatry and Behavioral Sciences at Stanford University. He is internationally recognized for discovering the cause of narcolepsy. His research focuses on the neurobiology, genetics, and immunology of narcolepsy, a disorder caused by hypocretin (orexin) cell loss, with an indirect interest in the neuroimmunology of other brain disorders.
Waking Up Narcolepsy and Brain Autoimmunity
Sendhil Mullainathan
Sendhil Mullainathan is the Roman Family University Professor of Computation and Behavioral Science at Chicago Booth. His current research uses machine learning to understand complex problems in human behavior, social policy, and especially medicine, where computational techniques have the potential to uncover biomedical insights from large-scale health data. He currently teaches a course on Artificial Intelligence.
Machine and Human Intelligence: Algorithms as a Source of Bias or Insight
Mira Murati
Mira Murati holds a Bachelor of Engineering from Thayer School of Engineering at Dartmouth. She is currently the SVP of Research, Product & Partnerships at OpenAI and has been working on practical applications of technology and its impact on society.
The Evolution of Machine Intelligence: Panel Discussion
George Poste
Dr. George Poste is Chief Scientist, Complex Adaptive Systems Initiative (CASI) at Arizona State University. This program links expertise across the university in research on synthetic biology, ubiquitous sensing and Healthcare informatics for personalized medicine.
Sustaining Healthcare Innovation in an Era of Constraint
Michael Rosbash
Michael Rosbash is a Professor of Biology and the Peter Gruber Professor of Neuroscience at Brandeis University. He is also an Investigator of the Howard Hughes Medical Institute. He received his Ph.D. from MIT in Biophysics and has received numerous awards including the 2017 Nobel Prize in Physiology or Medicine.
The Circadian Rhythm Story: Past, Present and Future
Dan Shefet
Dan Shefet is a French lawyer, born in Denmark, and the author of the individual specialist report to UNESCO on ‘Online Radicalization’, Expert with the Council of Europe on the Internet Ombudsman, and President of AAID. Dan holds a philosophy degree and a law degree from the University of Copenhagen in addition to law studies in France.
Regulating AI
Roy Smythe
Roy Smythe, M.D., is the Chief Executive Officer of SomaLogic, Inc., a leading-edge biotechnology company headquartered in Boulder, Colorado. During the course of his career, he has been an internationally recognized surgeon, biomedical scientist, academician, health system administrator, and healthcare business entrepreneur.
Authority, Power and Autonomy in Medicine
Jack Szostak
Dr. Szostak is a Professor of Chemistry and Chemical Biology at Harvard University, Professor of Genetics at Harvard Medical School, an Investigator of the Howard Hughes Medical Institute, and the Alex Rich Distinguished Investigator at Massachusetts General Hospital.
Ann Thor
Dr. Ann Thor is the Todd Professor and Chair of the Department of Pathology at the University of Colorado School Of Medicine, and the former Rader Professor and Chair of Pathology at the University of Oklahoma Health Sciences Center
The Host Cancer Interface: Obesity and Diabetes Promote Cancer Development and May Reduce Treatment Efficacy
Eric Trumbull
Eric Trumbull, Ph.D., is a retired professor of Theatre and Communications who made a living of sorts doing theatre of one kind or another – teaching theatre and directing productions in an educational setting and performing in local non-professional theatres.
23 & Us: Family Ties, Family Lies
Julia Vitarello
Julia Vitarello is founder and CEO of Mila’s Miracle Foundation. Her life has taken her from Washington, D.C., where she grew up, to Amherst College, where she pursued a liberal arts degree, and then to Italy, where she lived and worked for many years.
Truly Personalized Medicines for Ultra-Rare Diseases: New Opportunities in Genomic Medicine
Lynne Wolfe
Lynne has been a nurse for over 30 years and a Nurse Practitioner working with children and adults who have all types of rare diseases for 25 years.
Why Would Anyone Study Rare Diseases?
Timothy Yu
Dr. Tim Yu is a neurologist and researcher at Boston Children’s Hospital. A graduate of Harvard College, he completed his M.D. and Ph.D. at UC San Francisco and neurology residency at Massachusetts General Hospital and Brigham and Women’s Hospital.
Truly Personalized Medicines for Ultra-Rare Diseases: New Opportunities in Genomic Medicine Truly Personalized Medicines for Ultra-Rare Diseases: New Opportunities in Genomic Medicine